Dr. Alyson Freeman successfully defended her dissertation on January 14, 2010. Shown from left to right: Dissertation Chair Fred Bunz, M.D., Ph.D., Johns Hopkins School of Medicine, Dr. Alyson Freeman, Major Professor Alvaro Monteiro, Ph.D. Dr. Freeman accepted a postdoctoral fellowship in the lab Dr. Deborah Morrison at the National Cancer Institute. Following a successful postdoc which included a cover on Molecular Cell, Dr. Freeman has joined Novartis as a Research Investigator II.
Dr. Freeman's publication record while in the Program:
Rios-Doria J, Fay A, Velkova A, Monteiro A. Determining the Fate of Phosphorylated Histone H2AX. Cancer Biology & Therapy, 5:2, 142-144, February 2006.
Freeman AK, Dapic V, Monteiro AN. Negative Regulation of CHK2 Activity by Protein Phosphatase 2A is Modulated by DNA Damage. Cell Cycle. 2010 Feb; 9(4):736-47.
Alyson K Freeman and Alvaro N A Monteiro. 8:27.
Dr. Freeman's publication since graduation:
Freeman AK, Ritt DA, Morrison DK. The importance of Raf dimerization in cell signaling. Small GTPases. 2013 Jul-Sep;4(3):180-5. doi: 10.4161/sgtp.26117. Epub 2013 Aug 28. PMID: 23985533
Freeman AK, Ritt DA, Morrison DK. Effects of Raf dimerization and its inhibition on normal and disease-associated Raf signaling.Mol Cell. 2013 Feb 21;49(4):751-8. doi: 10.1016/j.molcel.2012.12.018. Epub 2013 Jan 24. PMID: 23352452
McKay MM, Freeman AK, Morrison DK. Complexity in KSR function revealed by Raf inhibitor and KSR structure studies. Small GTPases. 2011 Sep;2(5):276-281. Epub 2011 Sep 1. PMID: 22292131
Freeman AK, Morrison DK.14-3-3 Proteins: Diverse functions in cell proliferation and cancer progression. Semin Cell Dev Biol. 2011 Aug 22.